Cognitive Rehabilitation in Patients With Depression
1 other identifier
interventional
100
1 country
1
Brief Summary
Depression is a highly prevalent and debilitating mental disorder, ranked one of the leading causes of disability worldwide. Several studies have identified neuropsychological deficits in populations of depressed patients affecting domains including attention, memory and executive functioning. These deficits often persist even in patients whose depressive symptoms have remitted. Cognitive impairment in depression represent a core feature of depression, and a valuable target for intervention. Identification of methods that would lead to amelioration would be of great clinical interest, and cognitive rehabilitation (CR) could be a potential way of achieving this. To date few studies on cognitive rehabilitation in depression has been conducted, but the preliminary results are promising. Still the demonstration of long-term effects and evidence relating to improved daily life executive functioning (i.e., generalization) is lacking. In the present study different group-based cognitive rehabilitation interventions will be compared. The aim of the study is to investigate if a group-based "brain training" intervention can improve executive function in patients with active and remitted depression. Efficacy will be assessed immediately after intervention, but also six months after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Jan 2018
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2017
CompletedFirst Posted
Study publicly available on registry
November 9, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedNovember 14, 2017
November 1, 2017
2.4 years
November 7, 2017
November 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Behavior Rating Inventory of Executive Function (BRIEF: self and informant form)
Executive function in daily life (range:70-210). Higher score indicate greater executive dysfunction.
Change from baseline up to 6 months
Secondary Outcomes (13)
Performance on Conners Continuous Performance test III incl. CATA
change from baseline up to 6 months
Performance on Wisconsin Card Sorting Test
change from baseline up to 6 months
Performance on D-KEFS Color Word Interference Test
change from baseline up to 6 months
Performance on The Emotional Stroop
change from baseline up to 6 months
Performance on the Emo 1-back task
change from baseline up to 6 months
- +8 more secondary outcomes
Study Arms (2)
Goal Management Training
EXPERIMENTALComputerized Cognitive Training
EXPERIMENTALInterventions
9 GMT modules will be administered in 9X2 hour sessions (ten groups). Manualized intervention; metacognitive strategies for improving attention and problem solving.
9 modules will be administered in 9x1 hour session (ten groups). Computerized Cognitive Training using commercially available web-based platforms based on neuroplasticity, developed to target skills such as attention, memory, speed of processing and executive functioning. Homework assignment between sessions.
Eligibility Criteria
You may qualify if:
- Completed treatment for mild or moderate MDD
- Evidence of executive dysfunction in everyday life determined by (a) a structured interview or (b) a self-report Behavior Rating Inventory of Executive Function (BRIEF) T-score \< 55.
You may not qualify if:
- Cognitive, sensory, physical, or language impairment affecting the capacity to complete the training program.
- Premorbid neurological disease or insult and/or comorbid neurological disorder.
- Reported ongoing alcohol or substance abuse.
- Psychotic disorders.
- Actively suicidal.
- Personality disorder sever enough to interfere with the protocol.
- Not fluent in Norwegian language.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Lovisenberg Diakonale Hospitallead
- University of Oslocollaborator
- Yale Universitycollaborator
Study Sites (1)
Lovisenberg Diaconal Hospital
Oslo, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andreas Joner
Lovisenberg Diaconal Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2017
First Posted
November 9, 2017
Study Start
January 1, 2018
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
November 14, 2017
Record last verified: 2017-11